주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판
Press release

Featured articles from the journal CHEST®, January 2023

Glenview, Illnois | 2023년 1월 19일

Published monthly, the journal CHESTopens in new tab/window® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The January issueopens in new tab/window of the CHEST journal contains 50 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activitiesopens in new tab/window, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“Starting in late 2022, readers have been earning continuing medical education (CME) credit for reading select journal CHEST articles and completing a posttest through the CHEST education portalopens in new tab/window,” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “The articles eligible for CME in January are, ‘Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPDopens in new tab/window,’ which is highlighted below, and ‘Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosisopens in new tab/window.’”

Also included in the current issue of the journal CHEST:

  • COPD

A meta-analysis of 60 randomized clinical trials, “Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPDopens in new tab/window,” demonstrated a reduced all-cause mortality risk in patients treated with inhaled corticosteroids as part of their therapy regimen. A visual abstract for the research can be viewed hereopens in new tab/window.

Caption: Do Inhaled Corticosteroids Reduce All-Cause Mortality Risk in Patients With COPD? (Credit: Hong Chen, MD, et al. CHEST, January 2023, https://doi.org/10.1016/j.chest.2022.07.015opens in new tab/window).

  • Critical Care

Temporal Trends and Variation in Bronchoscopy Use for Acute Respiratory Failure in the United Statesopens in new tab/window” finds that the variable use of bronchoscopy among mechanically ventilated patients with respiratory failure suggests potentially unwarranted practice variation and need for further studies to clarify which patients may benefit from bronchoscopy. A visual abstract for the research can be viewed hereopens in new tab/window.

  • Thoracic Oncology

A research letter, “A Biomarker-Based Approach for the Determination of Sample Adequacy During Endobronchial Ultrasound-Guided Transbronchial Needle Aspirationopens in new tab/window,” finds that a multivariate biomarker approach accurately reflects endobronchial ultrasound-guided transbronchial needle aspiration samples arising from predominantly lymphoid tissue and is suitable for subsequent diagnostic testing. A podcast of experts discussing the research can be found hereopens in new tab/window.

  • Pulmonary Vascular

Original research, “Sex Differences in Outcomes of Percutaneous Pulmonary Artery Thrombectomy in Patients With Pulmonary Embolismopens in new tab/window,” finds that women had higher rates of in-hospital mortality, procedural bleeding, increased quantities of blood product transfusions and increased vascular complications. An editorial related to the research can be found hereopens in new tab/window.

---

Notes for editors

To view the entire January issue of CHEST journal (volume 163, issue 1), published by Elsevier, visit journal.chestnet.orgopens in new tab/window and follow @journal_CHESTopens in new tab/window on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at [email protected]opens in new tab/window.

About the journal CHEST®

The journal CHESTopens in new tab/window, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.orgopens in new tab/window.

About the American College of Chest Physicians

The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.opens in new tab/window

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.

연락처

LD

Laura DiMasi

PR and Communications Specialist

American College of Chest Physicians (CHEST)

Laura DiMasi 이메일